102 related articles for article (PubMed ID: 19684400)
1. Cognitive reserve in relation to abeta42 in patients converting from MCI to dementia - a follow-up report.
Rolstad S; Nordlund A; Eckerström C; Gustavsson MH; Zetterberg H; Wallin A
Dement Geriatr Cogn Disord; 2009; 28(2):110-5. PubMed ID: 19684400
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment--proof of concept.
Rolstad S; Nordlund A; Eckerström C; Gustavsson MH; Zetterberg H; Wallin A
Dement Geriatr Cogn Disord; 2009; 27(2):194-200. PubMed ID: 19225233
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949
[TBL] [Abstract][Full Text] [Related]
4. Increasing CSF phospho-tau levels during cognitive decline and progression to dementia.
Andersson C; Blennow K; Almkvist O; Andreasen N; Engfeldt P; Johansson SE; Lindau M; Eriksdotter-Jönhagen M
Neurobiol Aging; 2008 Oct; 29(10):1466-73. PubMed ID: 17512092
[TBL] [Abstract][Full Text] [Related]
5. White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Abeta42 levels.
Stenset V; Hofoss D; Johnsen L; Skinningsrud A; Berstad AE; Negaard A; Reinvang I; Gjerstad L; Fladby T
Acta Neurol Scand; 2008 Dec; 118(6):373-8. PubMed ID: 18510598
[TBL] [Abstract][Full Text] [Related]
6. Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid.
Englund H; Degerman Gunnarsson M; Brundin RM; Hedlund M; Kilander L; Lannfelt L; Pettersson FE
Neurodegener Dis; 2009; 6(4):139-47. PubMed ID: 19521063
[TBL] [Abstract][Full Text] [Related]
7. High education may offer protection against tauopathy in patients with mild cognitive impairment.
Rolstad S; Nordlund A; Eckerström C; Gustavsson MH; Blennow K; Olesen PJ; Zetterberg H; Wallin A
J Alzheimers Dis; 2010; 21(1):221-8. PubMed ID: 20413900
[TBL] [Abstract][Full Text] [Related]
8. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
[TBL] [Abstract][Full Text] [Related]
9. Cognitive reserve and anosognosia in questionable and mild dementia.
Spitznagel MB; Tremont G
Arch Clin Neuropsychol; 2005 Jun; 20(4):505-15. PubMed ID: 15896563
[TBL] [Abstract][Full Text] [Related]
10. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
[TBL] [Abstract][Full Text] [Related]
11. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
Kester MI; van der Vlies AE; Blankenstein MA; Pijnenburg YA; van Elk EJ; Scheltens P; van der Flier WM
Neurology; 2009 Oct; 73(17):1353-8. PubMed ID: 19858456
[TBL] [Abstract][Full Text] [Related]
12. Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performance.
Bleecker ML; Ford DP; Celio MA; Vaughan CG; Lindgren KN
Neurology; 2007 Jul; 69(5):470-6. PubMed ID: 17664406
[TBL] [Abstract][Full Text] [Related]
13. Progression of mild cognitive impairment to Alzheimer's disease: improved diagnostic value of the combined use of N200 latency and beta-amyloid(1-42) levels.
Papaliagkas VT; Anogianakis G; Tsolaki MN; Koliakos G; Kimiskidis VK
Dement Geriatr Cogn Disord; 2009; 28(1):30-5. PubMed ID: 19628938
[TBL] [Abstract][Full Text] [Related]
14. Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients.
Vicini Chilovi B; Conti M; Zanetti M; Mazzù I; Rozzini L; Padovani A
Dement Geriatr Cogn Disord; 2009; 27(4):390-8. PubMed ID: 19339777
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of mild cognitive impairment for dementia. The influence of case definition and age.
Baars MA; van Boxtel MP; Dijkstra JB; Visser PJ; van den Akker M; Verhey FR; Jolles J
Dement Geriatr Cogn Disord; 2009; 27(2):173-81. PubMed ID: 19202336
[TBL] [Abstract][Full Text] [Related]
16. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
[TBL] [Abstract][Full Text] [Related]
17. The influence of cognitive reserve on neuropsychological functioning following coronary artery bypass grafting (CABG).
Ropacki SA; Bert AA; Ropacki MT; Rogers BL; Stern RA
Arch Clin Neuropsychol; 2007 Jan; 22(1):73-85. PubMed ID: 17161581
[TBL] [Abstract][Full Text] [Related]
18. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
[TBL] [Abstract][Full Text] [Related]
19. [Dementia and the Dutch Reading Tests for Adults].
Berger H; Kunst M; Deelman BG
Tijdschr Gerontol Geriatr; 1996 Dec; 27(6):250-4. PubMed ID: 9026982
[TBL] [Abstract][Full Text] [Related]
20. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
